SLT Holdings’s Hims & Hers Health HIMS Stock Holding History

SLT Holdings’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,625	Closed	-$603K	–	153
2025 Q3	$603K	Buy	10,625 +2,500	+31%	+$128K	0.39%	60
2025 Q2	$405K	Buy	+8,125	New	+$367K	0.3%	62

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SLT Holdings's HIMS Position: Q4 2025 in Review

SLT Holdings sold out of Hims & Hers Health (HIMS) in Q4 2025, closing a stake of 10,625 shares — an estimated $603K sold.

SLT Holdings first reported a position in HIMS in Q2 2025 and held it in 2 quarters. The position peaked at $603K in Q3 2025. 485 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

SLT Holdings reported no remaining Hims & Hers Health position as of Q4 2025 after selling out during the quarter.
SLT Holdings sold 10,625 Hims & Hers Health shares in Q4 2025, an estimated $603K.
SLT Holdings first reported a position in Hims & Hers Health in Q2 2025 and held it in 2 quarters.
SLT Holdings's Hims & Hers Health position peaked at $603K in Q3 2025.
485 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on SLT Holdings's 13F filing for Q4 2025, filed 9 Feb 2026.